He is heading a new company for the development of Coegin’s cancer drug

The biotechnology company Coegin Pharma places the development of its drug candidate AVX420 in a newly formed company, Avexxin Oncology, based in Norway, and Jo...

Högteknologiska bolag allt mer intresserade av hälsa

Under många år har techföretag intresserat sig för hälso- och sjukvården och det intresset ser ut att öka. ”Det är inget plötsligt trendbrott, det handlar mer o...

No demand for new Covid vaccine – “It will probably be discarded”

So far, just under 6 000 doses of the Covid vaccine from Novavax have been used in Sweden, leaving over 1.4 million doses in stock. “They will probably be disca...

Stort vetenskapsmöte igång i Life City

Neanderthal genes and Nobel Prize in a popular lecture at Bioscience

An inherited gene variant from our ”evolutionary cousins” – the extinct Neanderthals – may affect how our bodies break down certain drugs. “It’s only a matter o...

"Are we doing business the wrong way around in the Life Science Sector?"

For the past 50 years we have created solutions for problems that we thought would solve the problems. Pharmaceuticals have created big block buster drugs which...

”Nya reglerna slår hårdast mot startuppföretagen”

Det stegvisa införandet av det nya regelverket IVDR löste en del problem – åtminstone tillfälligt. Men att sätta nya produkter på marknaden kommer att ta tid. D...

Column: ”Cheating with pea flowers and does it matter whether you are right?”

Is it possible to forgive shortcuts or outright cheating in science - if it turns out that the researcher was ultimately right? Anna Törner discuss this topic in a column.

Novavax is developing a vaccine candidate against Covid-19 and seasonal flu

A combined vaccine against both Covid-19 and seasonal flu is showing promising results in studies, according to the American drug developer Novavax. The adjuvan...

Conference on Alzheimer’s reveals several advances in the field

In Gothenburg, Sweden, researchers and pharmaceutical companies from all over the world gathered to discuss one specific issue – neurological diseases. Life Sci...

Han får vetenskapspris för upptäckten av den inflammatoriska reflexen

Den amerikanske neurokirurgen och uppfinnaren Kevin J. Tracey tilldelas Hans Wigzells Forskningsstiftelses vetenskapliga pris på 100 000 dollar. Han får det bla...

Låt inte spårbarheten bli din huvudvärk

Spårbarhet är avgörande inom branscher som Life Science, Livsmedel och Metall och det gäller att ha full koll från råvara till färdig produkt för att kunna leva...

Biosimilars bring price pressure, but are they sufficiently used?

When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...

Studie: Sobis läkemedel mot reumatism har effekt mot covid-19

Behandling med läkemedlet anakinra minskar risken för död i covid-19-relaterad lunginflammation, enligt en fas III-studie. Det uppger Swedish Orphan Biovitrum, Sobi.

Start-up developing ”digital twin” received award during the EIT Health Summit

A biotech company, a medtech company and a company in digital health were on the podium when the EIT Health Catapult awarded its winners.

BMS stämmer svenskt forskningsbolag för patentintrång

Den globala läkemedelsjätten Bristol-Myers Squibb (BMS) stämmer det svenska forskningsbolaget Xspray Pharma för patentintrång kopplat till läkemedelskandidaten Dasynoc.

“We are Europe’s hotspot in life science”

The Medicon Valley Alliance has worked for competence development in life science in Denmark and Sweden for a quarter of a century. Anette Steenberg, CEO, sees ...

FOKUS Patient turns international

FOKUS Patient is arranging conferences over 3 days in October, and this year, the focus will be on international collaborations.

333 miljoner till hjärt-lungforskning – drönarprojekt med hjärtstartare bland mottagarna

Hjärt-Lungfonden delar ut 333 miljoner kronor i form av 223 olika anslag till forskningsprojekt inom hjärta, kärl och lungor.

Webinar: How to Plan And Analyze a Real-World Evidence Study

This webinar is for drug developers who want to understand the basic ideas of analyzing an RWE study, as well as avoiding the most common pitfalls.

Nya data från Medivir vid cancerkongress

Forskningsbolaget Medivir har presenterat data för en trippelkombination med läkemedelskandidaten fostrox vid kongressen AACR 2023.

Now it’s settled: The International Vaccine Institute will be located in Stockholm

The International Vaccine Institute, IVI, is establishing itself outside South Korea for the first time. Last week, the Swedish Parliament ratified the agreemen...

MedVasc and Scientific Solutions join forces to streamline FDA 510(k) regulatory process

MedVasc, an exciting MedTech startup company, and Scientific Solutions, a renowned consulting firm within Life Science, are pleased to announce a strategic part...

Novo Nordisk invests billions in expanding its production capacity

Danish pharmaceutical company Novo Nordisk is making a major investment to develop and expand its production facility in Hillerød, north of Copenhagen. DKK 15.9...